Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10
- 2 August 2006
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 179 (1-2) , 46-52
- https://doi.org/10.1016/j.jneuroim.2006.06.020
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1Journal of General Virology, 2006
- Innate immune recognition of viral infectionNature Immunology, 2006
- Treatment of intravaginal HSV-2 infection in mice: A comparison of CpG oligodeoxynucleotides and resiquimod (R-848)Antiviral Research, 2005
- Toll‐like receptor 3 agonist poly(I:C)‐induced antiviral response in human corneal epithelial cellsImmunology, 2005
- Toll‐Like Receptor (TLR)–3, but Not TLR4, Agonist Protects against Genital Herpes Infection in the Absence of Inflammation Seen with CpG DNAThe Journal of Infectious Diseases, 2004
- The two NF-κB activation pathways and their role in innate and adaptive immunityPublished by Elsevier ,2004
- Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9Blood, 2004
- Effect of Anti-CXCL10 Monoclonal Antibody on Herpes Simplex Virus Type 1 Keratitis and Retinal InfectionJournal of Virology, 2003
- Local Delivery of CpG Oligodeoxynucleotides Induces Rapid Changes in the Genital Mucosa and Inhibits Replication, but Not Entry, of Herpes Simplex Virus Type 2Journal of Virology, 2003
- Molecular circuitry regulating herpes simplex virus type 1 latency in neuronsJournal of NeuroVirology, 2000